Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Shocking away pain: TENS modes compared for Post-Prostatectomy pelvic pain

NCT ID NCT07348952

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two different modes of transcutaneous electrical nerve stimulation (TENS) to relieve chronic pelvic pain in 60 men who had prostate surgery. Participants received TENS sessions three times a week for three months. The goal was to see which mode works better for reducing pain and stress-related cortisol levels.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Transcutaneous Electrical Nerve Stimulation (TENS) device
What this could lead to
If successful, this could point toward a more effective, non-drug way to manage chronic pelvic pain after prostate surgery.
What could go wrong
This is a small, completed study with 60 participants. Results may not apply to all patients, and the effect may be modest or not last long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Sep 2023

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

50 to 60 years

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients will be chosen after a routine medical examination. * All patients will be approximately the same age (from 50-60 years old). * All patients have chronic pudendal neuralgia post-prostatectomy surgery. * They have not take another physical therapy electro- modality except the traditional physical therapy in the form of pelvic floor exercises. * All of them will be non smokers and will be under own prescribed medications described by their physicians. * The pain is located in the pudendal nerve distribution area. * Pain intensity increased in the sitting position. * There were no symptoms of nocturnal pain. * Pain with no objective sensory impairment. * Pain was relieved by diagnostic pudendal nerve block. * Another clinical standard provides extra support to the diagnosis of pudendal neuralgia. * Pain symptoms may be associated with sexual dysfunction. Exclusion Criteria: * Patients have simple tailbone, gluteus muscle or lower abdominal pain, or only paroxysmal pain, or only pruritic symptoms, and/or having imaging anomalies that may explain the symptoms. * Patients who take anticoagulant drugs or have any coagulation disorder. * Patients who will be unable to complete the study. * Patients with pain, which is caused by malignant or autoimmune diseases. * Patients with life threatening disorders as renal failure, myocardial infarction or others will be excluded from the study. * Patients who suffering from skin diseases, diabetes, varicose veins, trauma and peripheral vascular diseases will be excluded. * Patients who suffering from myasthenia gravis, hyperthyroidism, hemorrhage, acute viral diseases, acute tuberculosis, mental disorders or those with pace makers will be excluded from the study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Post prostatectomy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • out-clinics of the general surgery department in Om-El Misrieen hospital

    Giza, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.